Metabolic Syndrome and Inflammatory Markers

The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Syndrome Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Males with metabolic syndrome

Exclusion criteria

Conditions with insulin resistance including;
Type 2 diabetes mellitus,
Infections,
Stresses,
Uremia,
Acromegaly,
Glucocorticoid excess,
Hypertension ,
Cirrhosis and
Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.

Treatment and study plan

Ramadan Fasting

Behavioral

Primary outcomes

Measuring inflammatory markers in metabolic syndrome

Sponsors and collaborators

Lead sponsor

Free Islamic University of Medical Sciences

Other

Registry information

Official study title

Effect of Fasting With Two Meals on Inflammatory Markers of Metabolic Syndrome

Important dates

Study start: 2006
Study completion: 2006
First posted: Feb 9, 2007
Registry last updated: Feb 9, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed